Psilocybin dose-dependently causes delayed, transient headaches in healthy volunteers
- 29 November 2011
- journal article
- research article
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 123 (1-3), 132-140
- https://doi.org/10.1016/j.drugalcdep.2011.10.029
Abstract
No abstract availableKeywords
This publication has 114 references indexed in Scilit:
- Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effectsPsychopharmacology, 2011
- The role of serotonin receptors in migraine headachesNeurochemical Journal, 2011
- Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months laterJournal of Psychopharmacology, 2008
- Human hallucinogen research: guidelines for safetyJournal of Psychopharmacology, 2008
- A Single Dose of Lysergic Acid Diethylamide Influences Gene Expression Patterns within the Mammalian BrainNeuropsychopharmacology, 2002
- Triptans in MigraineDrugs, 2000
- Is migraine prophylactic activity caused by 5-HT2B or 5-HT2C receptor blockade?Life Sciences, 1994
- Activation of cerebral guanylate cyclase by nitric oxideBiochemical and Biophysical Research Communications, 1977
- Hypersensitivity to lysergic acid diethylamide (LSD-25) and psilocybin in essential headacheCellular and Molecular Life Sciences, 1974
- Ueber PelloteNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1898